Cholesterol level was severely hindered in models of diabetes and Huntington’s disease, as a result of the downregulation of numerous genes involved in the cholesterol biosynthesis pathway, including SREBP2 (Suzuki et al., 2010; Birolini et al., 2021). Here, SREBF2 is linked to diabetes mellitus.